DISCOVERY AND EVALUATION OF NOVEL TRITERPENOID CHEMOPREVENTIVES IN A NEW COLON CA
DISCOVERY AND EVALUATION OF NOVEL TRITERPENOID CHEMOPREVENTIVES IN A NEW COLON CA
批准号:
7545051
负责人:
John James Letterio
金额:
$7.84万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-06-18 至 2010-05-31
关键词:
1-Phosphatidylinositol 3-Kinase2-cyano-3,12-dioxoolean-1,9-dien-28-oic acidAcuteAddressAdverse effectsAnimal ModelAnti-Inflammatory AgentsAnti-inflammatoryAntihypertensive AgentsAntineoplastic AgentsBiological FactorsBiological MarkersBiologyCancer Death RatesCancer PatientCancer cell lineCarcinomaCardiovascular DiseasesCardiovascular systemCellsChemicalsChemistryChemopreventionChemopreventive AgentChinese HerbsCholesterolClassClinicalClinical ResearchColonColon CarcinomaColonic NeoplasmsCommunicationCommunitiesCouplesCultured CellsDataDeath RateDetectionDevelopmentDietDiseaseDoctor of MedicineDoseDrug Delivery SystemsEarly DiagnosisEmployee StrikesEnhancersEnzymesEpigenetic ProcessEpithelialEpithelial CellsEstersEvaluationEventFamilyFutureGastrointestinal tract structureGene ExpressionGenesGenetic TranscriptionGenus ColaGerminationGoalsGrowth FactorHamartomatous PolypHeart DiseasesHumanHydroxyprostaglandin DehydrogenasesImidazoleImmuneIn VitroInfarctionInflammationInflammatoryInstitutionIntestinal NeoplasmsIntraperitoneal InjectionsJanus kinaseKnowledgeLaboratoriesLeucine ZippersLinkLymphocytic InfiltrateMADH4 geneMalignant NeoplasmsMalignant neoplasm of gastrointestinal tractMediatingModelingMolecularMusMutagenesisMutationNewly DiagnosedNon-Steroidal Anti-Inflammatory AgentsNuclearNumbersOleanolic AcidOncogenicOral AdministrationOxidative StressPTGS2 genePathway interactionsPatientsPharmaceutical ChemistryPharmaceutical PreparationsPharmacologic SubstancePharmacologyPhasePhase I Clinical TrialsPhenotypePlant RootsPre-Clinical ModelPreventionPrimary carcinoma of the liver cellsProcessPropertyRecurrenceRefractoryResearchResearch PersonnelRiskRoleSTAT proteinSTAT3 geneSafetyScientistSerumSignal TransductionSignaling MoleculeSkeletal systemSkeletonSourceStagingStandards of Weights and MeasuresSteroidsStressStructure-Activity RelationshipSyndromeSystemT-LymphocyteTNF geneTechniquesTestingTherapeuticTimeTransforming Growth FactorsTranslationsTumor Suppressor ProteinsUniversitiesVascular Endothelial Growth FactorsWomanWorkanticancer researchbryonolic acidcancer chemopreventioncancer preventioncarcinogenesiscelecoxibcyclooxygenase 2cytokinedaydesignfeedingfunctional groupgastrointestinalhuman NOS2A proteinimprovedin vivoinhibitor/antagonistknock-downknockout genelung Carcinomamacrophagemenmouse modelnovelnovel therapeuticsoleananepreventprototyperesponsesmall moleculesmall molecule librariestranscription factortumortumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The field of cancer chemoprevention represents a unique opportunity for the fruitful cooperation of basic scientists and clinical researchers to tackle a problem of acute need. One of the best examples to date of a potential cancer chemopreventive is the semisynthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid (CDDO), which was born out of a structure activity relationship (SAR) with the natural product oleanolic acid (from Chinese herbs). The proposed work described herein will expand our knowledge of triterpenoids as small molecule chemopreventives by focusing on bryonolic acid, a natural product abundantly produced in the roots of germinating Curcubita pepo L. (common zucchini). We aim to study the effect of this molecule on key inflammation-related markers of carcinogenesis and determine its potential as a pharmacologic chemopreventive with a special emphasis on colon cancer. To date we have devised a purification of this molecule yielding sub-gram quantities and illustrated its ability to inhibit the expression of iNOS and COX-2 in cell culture models. We are currently purifying multi-gram quantities of bryonolic acid and the goals of this proposal are centered on exploring the chemistry and biology of this molecule. Our two specific aims are: 1) to study the skeletal requirement of triterpenoid activity (for bryonolic acid and the entire triterpenoid family) using a diversity oriented synthesis (DOS) approach, and 2) determine whether triterpenoids are effective agents for the prevention of gastrointestinal carcinogenesis using cell culture and animal models. This proposal is strategically placed to potentially identify new chemopreventive agents which could be obtained from an abundant dietary source, but also to answer more fundamental questions about triterpenoids as chemopreventives. This project represents a collaborative endeavor between a synthetic organic chemist and a cancer biologist to address problems of cancer chemoprevention. The described aims will yield new molecules to be tested for their chemopreventive properties.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Small Molecule Induction of 15-PGDH: A Target in Colon Cancer Chemoprevention
-
批准号:9248208
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2013
-
负责人:John James Letterio
-
依托单位:
Small Molecule Induction of 15-PGDH: A Target in Colon Cancer Chemoprevention
-
批准号:9040105
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2013
-
负责人:John James Letterio
-
依托单位:
Small Molecule Induction of 15-PGDH: A Target in Colon Cancer Chemoprevention
-
批准号:8828504
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2013
-
负责人:John James Letterio
-
依托单位:
CdK5, OX40, and Immune Tolerance in Uveitis
-
批准号:9053492
-
项目类别:
-
资助金额:$39.66万
-
财政年份:2013
-
负责人:John James Letterio
-
依托单位:
Small Molecule Induction of 15-PGDH: A Target in Colon Cancer Chemoprevention
-
批准号:8505851
-
项目类别:
-
资助金额:$32.81万
-
财政年份:2013
-
负责人:John James Letterio
-
依托单位:
CdK5, OX40, and Immune Tolerance in Uveitis
-
批准号:8628128
-
项目类别:
-
资助金额:$39.22万
-
财政年份:2013
-
负责人:John James Letterio
-
依托单位:
CdK5, OX40, and Immune Tolerance in Uveitis
-
批准号:8812858
-
项目类别:
-
资助金额:$39.22万
-
财政年份:2013
-
负责人:John James Letterio
-
依托单位:
CdK5, OX40, and Immune Tolerance in Uveitis
-
批准号:8419629
-
项目类别:
-
资助金额:$41.35万
-
财政年份:2013
-
负责人:John James Letterio
-
依托单位:
DISCOVERY AND EVALUATION OF NOVEL TRITERPENOID CHEMOPREVENTIVES IN A NEW COLON CA
-
批准号:7641064
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2008
-
负责人:John James Letterio
-
依托单位:
Developmental Therapeutics Research Program
-
批准号:10380717
-
项目类别:
-
资助金额:$5.51万
-
财政年份:1997
-
负责人:John James Letterio
-
依托单位:
Developmental Therapeutics Research Program
-
批准号:10784825
-
项目类别:
-
资助金额:$9.32万
-
财政年份:1997
-
负责人:John James Letterio
-
依托单位:
Developmental Therapeutics Research Program
-
批准号:9904162
-
项目类别:
-
资助金额:$5.1万
-
财政年份:--
-
负责人:John James Letterio
-
依托单位: